Zumutor Biologics Secures $7.3 Mn To Advance Clinical Trials For Cancer Therapy
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Zumutor Biologics secured $7.3 million in fresh funding to advance its clinical-stage cancer therapy work, per the report's headline.
- The capital raise is directed specifically at progressing clinical trials for the biotech's cancer treatment program, the stated use of proceeds.
Why it matters: The $7.3 Mn raise gives Zumutor Biologics dedicated capital to push its cancer therapy into clinical trials, a concrete funding checkpoint for the biotech's oncology pipeline. The source provides no detail on lead investors, round type, or the specific therapy or trial phase being advanced.
Ask SkimNews
